"variable_name","dataset","code_list","definition"
"bmu","Community engagement",,"Number of TB Basic Management Units in the country"
"bmu_community_impl","Community engagement",,"Number of TB Basic Management Units which implemented community-based referrals or any form of community treatment adherence support"
"bmu_ref_data","Community engagement",,"Number of Basic Management Units with data on referrals by community health workers / community volunteers"
"bmu_rxsupport_data","Community engagement",,"Number of Basic Management Units with data on community treatment adherence support"
"bmu_rxsupport_data_coh","Community engagement",,"Total number of patients who started TB treatment in the Basic Management Units with data on community treatment adherence support"
"community_data_available","Community engagement","0=No; 1=Yes","Are data available on community-based referrals or any form of community treatment adherence support?"
"notified_ref","Community engagement",,"Total number of new and relapse TB cases notified in the Basic Management Units with data on referrals by community health workers"
"notified_ref_community","Community engagement",,"Total number of new and relapse TB cases referred by community health workers / community volunteers in the Basic Management Units with data on referrals by community health workers"
"rxsupport_community_coh","Community engagement",,"Total number of patients who started TB treatment and who received any form of treatment adherence support from community health workers / community volunteers in the Basic Management Units with data on community treatment adherence support"
"rxsupport_community_succ","Community engagement",,"Total number of patients who were cured or who completed treatment among the cases who started TB treatment and who received any form of treatment adherence support from community health workers / community volunteers in the Basic Management Units with data on community treatment adherence support"
"country","Country identification",,"Country or territory name"
"iso_numeric","Country identification",,"ISO numeric country/territory code"
"iso2","Country identification",,"ISO 2-character country/territory code"
"iso3","Country identification",,"ISO 3-character country/territory code"
"c_cdr","Estimates",,"Case detection rate (all forms), percent"
"c_cdr_hi","Estimates",,"Case detection rate (all forms), percent, high bound"
"c_cdr_lo","Estimates",,"Case detection rate (all forms), percent, low bound"
"c_newinc_100k","Estimates",,"Case notification rate, which is the total of new and relapse cases and cases with unknown previous TB treatment history per 100 000 population (calculated)"
"cfr","Estimates",,"Estimated TB case fatality ratio"
"cfr_hi","Estimates",,"Estimated TB case fatality ratio: high bound"
"cfr_lo","Estimates",,"Estimated TB case fatality ratio: low bound"
"e_inc_100k","Estimates",,"Estimated incidence (all forms) per 100 000 population"
"e_inc_100k_hi","Estimates",,"Estimated incidence (all forms) per 100 000 population, high bound"
"e_inc_100k_lo","Estimates",,"Estimated incidence (all forms) per 100 000 population, low bound"
"e_inc_num","Estimates",,"Estimated number of incident cases (all forms)"
"e_inc_num_014","Estimates",,"Estimated number of incident cases that are aged 0 - 14"
"e_inc_num_014_hi","Estimates",,"Estimated number of incident cases that are male 0 - 14 (upper bound)"
"e_inc_num_014_lo","Estimates",,"Estimated number of incident cases that are aged 0 - 14 (lower bound)"
"e_inc_num_15plus","Estimates",,"Estimated number of incident cases that are aged 15 and over"
"e_inc_num_15plus_hi","Estimates",,"Estimated number of incident cases that are aged 15 and over (upper bound)"
"e_inc_num_15plus_lo","Estimates",,"Estimated number of incident cases that are aged 15 and over (lower bound)"
"e_inc_num_f","Estimates",,"Estimated number of incident cases that are female"
"e_inc_num_f_hi","Estimates",,"Estimated number of incident cases that are female (upper bound)"
"e_inc_num_f_lo","Estimates",,"Estimated number of incident cases that are female (lower bound)"
"e_inc_num_f014","Estimates",,"Estimated number of incident cases that are female aged 0 - 14"
"e_inc_num_f014_hi","Estimates",,"Estimated number of incident cases that are female aged 0 - 14 (upper bound)"
"e_inc_num_f014_lo","Estimates",,"Estimated number of incident cases that are female aged 0 - 14 (lower bound)"
"e_inc_num_f15plus","Estimates",,"Estimated number of incident cases that are female aged 15 and over"
"e_inc_num_f15plus_hi","Estimates",,"Estimated number of incident cases that are female aged 15 and over (upper bound)"
"e_inc_num_f15plus_lo","Estimates",,"Estimated number of incident cases that are female aged 15 and over (lower bound)"
"e_inc_num_hi","Estimates",,"Estimated number of incident cases (all forms), high bound"
"e_inc_num_lo","Estimates",,"Estimated number of incident cases (all forms), low bound"
"e_inc_num_m","Estimates",,"Estimated number of incident cases that are male"
"e_inc_num_m_hi","Estimates",,"Estimated number of incident cases that are male (upper bound)"
"e_inc_num_m_lo","Estimates",,"Estimated number of incident cases that are male (lower bound)"
"e_inc_num_m014","Estimates",,"Estimated number of incident cases that are male aged 0 - 14"
"e_inc_num_m014_hi","Estimates",,"Estimated number of incident cases that are male aged 0 - 14 (upper bound)"
"e_inc_num_m014_lo","Estimates",,"Estimated number of incident cases that are male aged 0 - 14 (lower bound)"
"e_inc_num_m15plus","Estimates",,"Estimated number of incident cases that are male aged 15 and over"
"e_inc_num_m15plus_hi","Estimates",,"Estimated number of incident cases that are male aged 15 and over (upper bound)"
"e_inc_num_m15plus_lo","Estimates",,"Estimated number of incident cases that are male aged 15 and over (lower bound)"
"e_inc_rr_num","Estimates",,"Estimated incidence of rifampicin resistant TB (absolute number)"
"e_inc_rr_num_hi","Estimates",,"Estimated incidence of rifampicin resistant TB (absolute number): high bound"
"e_inc_rr_num_lo","Estimates",,"Estimated incidence of rifampicin resistant TB (absolute number): low bound"
"e_inc_tbhiv_100k","Estimates",,"Estimated incidence of TB cases who are HIV-positive per 100 000 population"
"e_inc_tbhiv_100k_hi","Estimates",,"Estimated incidence of TB cases who are HIV-positive per 100 000 population, high bound"
"e_inc_tbhiv_100k_lo","Estimates",,"Estimated incidence of TB cases who are HIV-positive per 100 000 population, low bound"
"e_inc_tbhiv_num","Estimates",,"Estimated incidence of TB cases who are HIV-positive"
"e_inc_tbhiv_num_hi","Estimates",,"Estimated incidence of TB cases who are HIV-positive, high bound"
"e_inc_tbhiv_num_lo","Estimates",,"Estimated incidence of TB cases who are HIV-positive, low bound"
"e_mdr_pct_rr_new","Estimates",,"Estimated percentage of new rifampicin resistant TB cases that have MDR-TB"
"e_mdr_pct_rr_ret","Estimates",,"Estimated percentage of previously treated rifampicin resistant TB cases that have MDR-TB"
"e_mort_exc_tbhiv_100k","Estimates",,"Estimated mortality of TB cases (all forms, excluding HIV) per 100 000 population"
"e_mort_exc_tbhiv_100k_hi","Estimates",,"Estimated mortality of TB cases (all forms, excluding HIV), per 100 000 population, high bound"
"e_mort_exc_tbhiv_100k_lo","Estimates",,"Estimated mortality of TB cases (all forms, excluding HIV), per 100 000 population, low bound"
"e_mort_exc_tbhiv_num","Estimates",,"Estimated number of deaths from TB (all forms, excluding HIV)"
"e_mort_exc_tbhiv_num_hi","Estimates",,"Estimated number of deaths from TB (all forms, excluding HIV), high bound"
"e_mort_exc_tbhiv_num_lo","Estimates",,"Estimated number of deaths from TB (all forms, excluding HIV), low bound"
"e_mort_tbhiv_100k","Estimates",,"Estimated mortality of TB cases who are HIV-positive, per 100 000 population"
"e_mort_tbhiv_100k_hi","Estimates",,"Estimated mortality of TB cases who are HIV-positive, per 100 000 population, high bound"
"e_mort_tbhiv_100k_lo","Estimates",,"Estimated mortality of TB cases who are HIV-positive, per 100 000 population, low bound"
"e_mort_tbhiv_num","Estimates",,"Estimated number of deaths from TB in people who are HIV-positive"
"e_mort_tbhiv_num_hi","Estimates",,"Estimated number of deaths from TB in people who are HIV-positive, high bound"
"e_mort_tbhiv_num_lo","Estimates",,"Estimated number of deaths from TB in people who are HIV-positive, low bound"
"e_pop_num","Estimates",,"Estimated total population number"
"e_rr_in_notified_pulm","Estimates",,"Estimated number of RR-TB cases among notified pulmonary TB cases"
"e_rr_in_notified_pulm_hi","Estimates",,"Estimated number of RR-TB cases among notified pulmonary TB cases: high bound"
"e_rr_in_notified_pulm_lo","Estimates",,"Estimated number of RR-TB cases among notified pulmonary TB cases: low bound"
"e_rr_pct_new","Estimates",,"Estimated percentage of new TB cases with rifampicin resistant TB"
"e_rr_pct_new_hi","Estimates",,"Estimated percentage of new TB cases with rifampicin resistant TB: high bound"
"e_rr_pct_new_lo","Estimates",,"Estimated percentage of new TB cases with rifampicin resistant TB: low bound"
"e_rr_pct_ret","Estimates",,"Estimated percentage of previously treated TB cases with rifampicin resistant TB"
"e_rr_pct_ret_hi","Estimates",,"Estimated percentage of previously treated TB cases with rifampicin resistant TB: high bound"
"e_rr_pct_ret_lo","Estimates",,"Estimated percentage of previously treated TB cases with rifampicin resistant TB: low bound"
"e_tbhiv_prct","Estimates",,"Estimated HIV in incident TB (percent)"
"e_tbhiv_prct_hi","Estimates",,"Estimated HIV in incident TB (percent), high bound"
"e_tbhiv_prct_lo","Estimates",,"Estimated HIV in incident TB (percent), low bound"
"source_drs_coverage_new","Estimates",,"Indicates whether national or subnational data from drug resistance surveys or surveillance was used to estimate the proportion of new TB cases with MDR-TB"
"source_drs_coverage_ret","Estimates",,"Indicates whether national or subnational data from drug resistance surveys or surveillance was used to estimate the proportion of previously treated TB cases with MDR-TB"
"source_drs_year_new","Estimates",,"Year of drug resistance surveillance, survey or model used to estimate proportion of new TB cases with MDR-TB"
"source_drs_year_ret","Estimates",,"Year of drug resistance surveillance, survey or model used to estimate proportion of previously treated TB cases with MDR-TB"
"source_rr_new","Estimates",,"Method used to estimate proportion of new TB patients with rifampicin-resistant TB"
"source_rr_ret","Estimates",,"Method used to estimate proportion of previously treated TB patients with rifampicin-resistant TB"
"collab_private_lab","Laboratories","0=No; 1=yes","Were any non-NTP laboratories in the private sector (including NGOs) collaborating with the NTP?"
"collab_public_lab","Laboratories","0=No; 1=yes","Were any non-NTP laboratories in the public sector collaborating with the NTP?"
"culture","Laboratories",,"Number of sites providing TB diagnostic services using culture at the end of the reporting year"
"dst","Laboratories",,"Number of sites providing phenotypic drug susceptibility testing for first-line drugs only at the end of the reporting year"
"dst_eqa_pass","Laboratories",,"Number of sites providing phenotypic drug susceptibility testing for first-line drugs only that demonstrated proficiency by panel testing"
"lab_cul","Laboratories",,"Number of laboratories providing TB diagnostic services using culture"
"lab_dst","Laboratories",,"Number of laboratories providing TB diagnostic services using drug susceptibility testing"
"lab_dst_eqa","Laboratories",,"Number of drug susceptibility testing laboratories for which External Quality Assessment (EQA) was carried out"
"lab_dst_eqa_pass","Laboratories",,"Number of drug susceptibility testing laboratories which demonstrated acceptable performance"
"lab_lpa","Laboratories",,"Number of laboratories providing TB diagnostic services using Line Probe Assay (LPA) rifampicin"
"lab_lpa_eqa","Laboratories",,"Number of Line Probe Assay (LPA) rifampicin  laboratories for which External Quality Assessment (EQA) was carried out"
"lab_lpa_eqa_pass","Laboratories",,"Number of Line Probe Assay (LPA) rifampicin laboratories which demonstrated acceptable performance"
"lab_sm","Laboratories",,"Number of laboratories providing TB diagnostic services using smear microscopy"
"lab_sm_eqa","Laboratories",,"Number of smear microscopy laboratories for which External Quality Assessment (EQA) was carried out"
"lab_sm_eqa_pass","Laboratories",,"Number of smear microscopy laboratories which demonstrated acceptable performance"
"lab_sm_led","Laboratories",,"Number of laboratories providing TB diagnostic services using LED microscopes for smear microscopy"
"lab_xpert","Laboratories",,"Number of laboratories providing TB diagnostic services using xpert MTB/RIF"
"lab_xpert_eqa","Laboratories",,"Number of laboratories providing TB diagnostic services using xpert MTB/RIF for which External Quality Assessment (EQA) was carried out"
"lpa","Laboratories",,"Number of sites providing Line Probe Assay services at the end of the reporting year"
"lpa_eqa_pass","Laboratories",,"Number of sites providing Line Probe Assay services that demonstrated proficiency by panel testing"
"nrl","Laboratories","0=No; 1=yes","Was there a national reference laboratory or laboratories (NRL)?"
"nrl_iso15189","Laboratories","0=No; 1=yes","Has the national reference laboratory (or national reference laboratories) achieved national or international accreditation according to the ISO 15189 standard?"
"nrl_qms","Laboratories","0=No; 1=yes","Has a formal quality management system towards achieving laboratory accreditation been implemented at the National Reference Laboratory?"
"nrl_srl_link","Laboratories","0=No; 1=yes","Has a formal link been established between the National Reference Laboratory and a partner Supranational Reference Laboratory?"
"qms","Laboratories","0=No; 1=yes","Is a formal quality management system towards achieving accreditation being implemented in all laboratories conducting culture, LPA and/or DST?"
"sldst","Laboratories",,"Number of sites providing phenotypic drug susceptibility testing for first-line drugs and second-line drugs at the end of the reporting year"
"sldst_avail_incntry","Laboratories","0=No; 1=yes","Was second-line drug susceptibility testing available within the country for TB National Treatment Programme patients?"
"sldst_avail_outcntry","Laboratories","0=No; 1=yes","Was second-line drug susceptibility testing available outside the country for TB National Treatment Programme patients?"
"sldst_eqa_pass","Laboratories",,"Number of sites providing phenotypic drug susceptibility testing for first-line drugs and second-line drugs that demonstrated proficiency by panel testing"
"sllpa","Laboratories",,"Number of sites providing Line Probe Assay (LPA) services for rifampicin, isoniazid, fluoroquinolones, second-line injectables"
"sllpa_eqa_pass","Laboratories",,"Number of sites providing Line Probe Assay (LPA) services for rifampicin, isoniazid, fluoroquinolones, second-line injectables that demonstrated proficiency by panel testing"
"smear","Laboratories",,"Number of sites providing TB diagnostic services using smear microscopy at the end of the reporting year"
"smear_eqa","Laboratories",,"Number of sites providing TB diagnostic services using smear microscopy covered by a comprehensive EQA system"
"xpert","Laboratories",,"Number of sites providing TB diagnostic services using Xpert MTB/RIF at the end of the reporting year"
"xpert_eqa","Laboratories",,"Number of sites providing TB diagnostic services using Xpert MTB/RIF covered by a comprehensive EQA system"
"xpert_etrans","Laboratories",,"Number of sites using Xpert MTB/RIF which transmit results automatically to clinicians and to an information management system"
" e_prevtx_kids_pct","Latent TB infection",,"Estimated % of children received TB preventive therapy aged under 5 who are household contacts of TB cases and who are eligible for TB preventive therapy"
" e_prevtx_kids_pct_hi","Latent TB infection",,"Estimated % of children received TB preventive therapy aged under 5 who are household contacts of TB cases and who are eligible for TB preventive therapy: High bound"
" e_prevtx_kids_pct_lo","Latent TB infection",,"Estimated % of children received TB preventive therapy aged under 5 who are household contacts of TB cases and who are eligible for TB preventive therapy: Low bound"
"e_hh_size","Latent TB infection",,"Estimated average household size"
"e_prevtx_eligible","Latent TB infection",,"Estimated number of children aged under 5 who are household contacts of TB cases who are eligible for TB preventive therapy"
"e_prevtx_eligible_hi","Latent TB infection",,"Estimated number of children aged under 5 who are household contacts of TB cases who are eligible for TB preventive therapy: high bound"
"e_prevtx_eligible_lo","Latent TB infection",,"Estimated number of children aged under 5 who are household contacts of TB cases who are eligible for TB preventive therapy: low bound"
"newinc_con04_prevtx","Latent TB infection",,"(If prevtx_data_available=60) Number of children aged under 5 started on TB preventive therapy who are household contacts of bacteriologically-confirmed new and relapse TB cases notified"
"prevtx_data_available","Latent TB infection","0=No; 60= Yes available from the routine surveillance system; 61=Yes  estimated from a survey of a random sample of medical records or treatment cards of TB patients representative of the national TB patient population","Are data available on the number of children aged under 5 who are household contacts of TB cases and started on TB preventive therapy?"
"ptsurvey_newinc","Latent TB infection",,"(If prevtx_data_available=61) Number of bacteriologically-confirmed TB new and relapse cases notified in the reporting year whose medical records or treatment cards were included in a survey"
"ptsurvey_newinc_con04_prevtx","Latent TB infection",,"(If prevtx_data_available=61) Number of children aged under 5 started on TB preventive therapy who are household contacts of the TB cases in ptsurvey_newinc"
"source_hh","Latent TB infection",,"Source of estimate of average household size"
"tbhiv_sentin_cil","Non-routine HIV surveillance",,"Lower limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using sentinel sites"
"tbhiv_sentin_ciu","Non-routine HIV surveillance",,"Upper limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using sentinel sites"
"tbhiv_sentin_prev","Non-routine HIV surveillance",,"Prevalence (%) of HIV in TB patients estimated using sentinel sites"
"tbhiv_sentin_yr","Non-routine HIV surveillance",,"Year in which prevalence of HIV in TB patients was estimated using sentinel sites"
"tbhiv_surv_cil","Non-routine HIV surveillance",,"Lower limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using nationwide representative surveys"
"tbhiv_surv_ciu","Non-routine HIV surveillance",,"Upper limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using nationwide representative surveys"
"tbhiv_surv_prev","Non-routine HIV surveillance",,"Prevalence (%) of HIV in TB patients estimated using nationwide representative
surveys"
"tbhiv_surv_yr","Non-routine HIV surveillance",,"Year in which prevalence of HIV in TB patients was estimated using nationwide representative surveys"
"all_conf_xdr","Notification",,"Number of laboratory-confirmed XDR-TB cases identified in the current year (including in MDR cases diagnosed in previous years)."
"c_newinc","Notification",,"Total of new and relapse cases and cases with unknown previous TB treatment history"
"conf_mdr","Notification",,"Number of laboratory-confirmed MDR-TB cases identified"
"conf_mdr_tx","Notification",,"Number of laboratory-confirmed MDR-TB patients who started treatment for MDR-TB"
"conf_rrmdr","Notification",,"Number of laboratory-confirmed RR-TB or MDR-TB cases identified"
"conf_rrmdr_tx","Notification",,"Number of laboratory-confirmed rifampicin-resistant (RR-TB) or multidrug-resistant TB (MDR-TB) patients who started treatment for MDR-TB"
"conf_xdr_tx","Notification",,"Number of laboratory-confirmed XDR-TB patients who started treatment for XDR-TB"
"dst_rlt_new","Notification",,"Drug resistance surveillance: Among new TB patients with positive identification for M. Tuberculosis complex (confirmed by culture and/or line-probe assay): number of patients with available drug susceptibility testing results for isoniazid and rifampicin"
"dst_rlt_ret","Notification",,"Drug resistance surveillance: Among patients previously treated for TB with positive identification for M. Tuberculosis complex (confirmed by culture and/or line-probe assay): number of patients with available drug susceptibility testing results for isoniazid and rifampicin"
"dst_rlt_unk","Notification",,"Drug resistance surveillance: Among patients with unknown TB treatment history with positive identification for M. Tuberculosis complex (confirmed by culture and/or line-probe assay): number of patients with available drug susceptibility testing results for isoniazid and rifampicin"
"hiv_art","Notification",,"HIV-positive TB patients started or continued on antiretroviral therapy (ART)"
"hiv_cpt","Notification",,"HIV-positive TB patients started or continued on co-trimoxazole preventive therapy (CPT)"
"hiv_ipt","Notification",,"People registered as HIV-positive given isoniazid prophylaxis (treatment of latent TB infection)"
"hiv_reg","Notification",,"Total number of people registered as HIV-positive regardless of year of diagnosis. (Total number of adults and children enrolled in HIV care; includes everyone in the HIV care and/or ART register)"
"hiv_reg_new","Notification",,"Number of adults and children newly enrolled in HIV care during the year."
"hiv_reg_new2","Notification",,"Total number of adults and children newly enrolled in pre-ART care or on ART during the reporting period"
"hiv_tbdetect","Notification",,"Total number of adults and children newly enrolled in HIV care who are diagnosed as having active TB disease during the reporting period"
"hiv_tbscr","Notification",,"Number of adults and children enrolled in HIV care who had their TB status assessed and recorded during their last visit"
"hivtest","Notification",,"TB patients (new and re-treatment) with an HIV test result recorded in the TB register"
"hivtest_pos","Notification",,"TB patients (new and re-treatment) recorded as HIV-positive"
"mdr_dst_rlt","Notification",,"Drug resistance surveillance: Total number of MDR-TB patients with drug susceptibility test results for any fluoroquinolone and any second-line injectable agent"
"mdr_new","Notification",,"Drug resistance surveillance: Among new TB patients with available drug susceptibility testing results (variable dst_rlt_new):  number of patients with resistance to isoniazid and rifampicin  (MDR-TB)"
"mdr_ret","Notification",,"Drug resistance surveillance: Among patients previously treated for TB with available drug susceptibility testing results (variable dst_rlt_ret):  number of patients with resistance to isoniazid and rifampicin  (MDR-TB)"
"mdr_shortreg_tx","Notification",,"Number of patients started on shorter MDR-TB treatment regiments during the reporting year"
"mdr_shortreg_used","Notification","0=No; 1=Yes; 3=Don't know","Had any patients been started on shorter MDR-TB treatment regimens by the end of the reporting year?"
"mdr_tx_adverse_events","Notification",,"Number of patients on MDR-TB treatment who had adverse events registered in the reporting year"
"mdr_unk","Notification",,"Drug resistance surveillance: Among patients with unknown TB treatment history with available drug susceptibility testing results (variable dst_rlt_unk):  number of patients with resistance to isoniazid and rifampicin  (MDR-TB)"
"mdrxdr_bdq_tx","Notification",,"Number of patients started on Bedaquiline during the reporting year"
"mdrxdr_bdq_used","Notification","0=No; 1=Yes; 3=Don't know","Had any TB patients been started on Bedaquiline for the treatment of MDR-/XDR-TB by the end of reporting year as part of expanded access, compassionate use or under normal programmatic use, whether in the public or private sector?"
"mdrxdr_dlm_used","Notification","0=No; 1=Yes; 3=Don't know","Had any TB patients been started on Delamanid for the treatment of MDR-/XDR-TB by the end of reporting as part of expanded access, compassionate use or under normal programmatic use, whether in the public or private sector?"
"new_clindx","Notification",,"New pulmonary clinically diagnosed TB cases (not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment).  It also includes pulmonary clinically diagnosed cases with unknown previous TB treatment history."
"new_ep","Notification",,"New extrapulmonary cases (bacteriologically confirmed or clinically diagnosed). As of 2013 this also includes extrapulmonary cases with unknown previous TB treatment history."
"new_ep_f014","Notification",,"New extrapulmonary cases: females aged 0-14 years (not used after 2012)"
"new_ep_f04","Notification",,"New extrapulmonary cases: females aged 0-4 years (not used after 2012)"
"new_ep_f1524","Notification",,"New extrapulmonary cases: females aged 15-24 years (not used after 2012)"
"new_ep_f15plus","Notification",,"New extrapulmonary cases: females aged 15 years and over (not used after 2012)"
"new_ep_f2534","Notification",,"New extrapulmonary cases: females aged 25-34 years (not used after 2012)"
"new_ep_f3544","Notification",,"New extrapulmonary cases: females aged 35-44 years (not used after 2012)"
"new_ep_f4554","Notification",,"New extrapulmonary cases: females aged 45-54 years (not used after 2012)"
"new_ep_f514","Notification",,"New extrapulmonary cases: females aged 5-14 years (not used after 2012)"
"new_ep_f5564","Notification",,"New extrapulmonary cases: females aged 55-64 years (not used after 2012)"
"new_ep_f65","Notification",,"New extrapulmonary cases: females aged 65 years and over (not used after 2012)"
"new_ep_fu","Notification",,"New extrapulmonary cases: females age unknown (not used after 2012)"
"new_ep_m014","Notification",,"New extrapulmonary cases: males aged 0-14 years (not used after 2012)"
"new_ep_m04","Notification",,"New extrapulmonary cases: males aged 0-4 years (not used after 2012)"
"new_ep_m1524","Notification",,"New extrapulmonary cases: males aged 15-24 years (not used after 2012)"
"new_ep_m15plus","Notification",,"New extrapulmonary cases: males aged 15 years and over (not used after 2012)"
"new_ep_m2534","Notification",,"New extrapulmonary cases: males aged 25-34 years (not used after 2012)"
"new_ep_m3544","Notification",,"New extrapulmonary cases: males aged 35-44 years (not used after 2012)"
"new_ep_m4554","Notification",,"New extrapulmonary cases: males aged 45-54 years (not used after 2012)"
"new_ep_m514","Notification",,"New extrapulmonary cases: males aged 5-14 years (not used after 2012)"
"new_ep_m5564","Notification",,"New extrapulmonary cases: males aged 55-64 years (not used after 2012)"
"new_ep_m65","Notification",,"New extrapulmonary cases: males aged 65 years and over (not used after 2012)"
"new_ep_mu","Notification",,"New extrapulmonary cases: males age unknown (not used after 2012)"
"new_ep_sexunk014","Notification",,"New extrapulmonary cases: sex unknown, aged 0-14 years (not used after 2012)"
"new_ep_sexunk04","Notification",,"New extrapulmonary cases: sex unknown, aged 0-4 years (not used after 2012)"
"new_ep_sexunk15plus","Notification",,"New extrapulmonary cases: sex unknown, aged 15 years and over (not used after 2012)"
"new_ep_sexunk514","Notification",,"New extrapulmonary cases: sex unknown, aged 5-14 years (not used after 2012)"
"new_ep_sexunkageunk","Notification",,"New extrapulmonary cases: sex unknown, age unknown (not used after 2012)"
"new_labconf","Notification",,"New pulmonary bacteriologically confirmed TB cases (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF). As of 2013 this also includes pulmonary bacteriologically confirmed cases with unknown previous TB treatment history."
"new_oth","Notification",,"Other new cases (not used after 2012)"
"new_sn","Notification",,"New pulmonary smear-negative cases (not used after 2012)"
"new_sn_f014","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 0-14 years (not used after 2012)"
"new_sn_f04","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 0-4 years (not used after 2012)"
"new_sn_f1524","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 15-24 years (not used after 2012)"
"new_sn_f15plus","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 15 years and over (not used after 2012)"
"new_sn_f2534","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 25-34 years (not used after 2012)"
"new_sn_f3544","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 35-44 years (not used after 2012)"
"new_sn_f4554","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 45-54 years (not used after 2012)"
"new_sn_f514","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 5-14 years (not used after 2012)"
"new_sn_f5564","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 55-64 years (not used after 2012)"
"new_sn_f65","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females aged 65 years and over (not used after 2012)"
"new_sn_fu","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: females age unknown (not used after 2012)"
"new_sn_m014","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 0-14 years (not used after 2012)"
"new_sn_m04","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 0-4 years (not used after 2012)"
"new_sn_m1524","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 15-24 years (not used after 2012)"
"new_sn_m15plus","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 15 years and above (not used after 2012)"
"new_sn_m2534","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 25-34 years (not used after 2012)"
"new_sn_m3544","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 35-44 years (not used after 2012)"
"new_sn_m4554","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 45-54 years (not used after 2012)"
"new_sn_m514","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 5-14 years (not used after 2012)"
"new_sn_m5564","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 55-64 years (not used after 2012)"
"new_sn_m65","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males aged 65 years and over (not used after 2012)"
"new_sn_mu","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: males age unknown (not used after 2012)"
"new_sn_sexunk014","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 0-14 years (not used after 2012)"
"new_sn_sexunk04","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 0-4 years (not used after 2012)"
"new_sn_sexunk15plus","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 15 years and over (not used after 2012)"
"new_sn_sexunk514","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 5-14 years (not used after 2012)"
"new_sn_sexunkageunk","Notification",,"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, age unknown (not used after 2012)"
"new_sp","Notification",,"New pulmonary smear-positive cases (not used after 2012)"
"new_sp_f014","Notification",,"New pulmonary smear positive cases: females aged 0-14 years (not used after 2012)"
"new_sp_f04","Notification",,"New pulmonary smear positive cases: females aged 0-4 years (not used after 2012)"
"new_sp_f1524","Notification",,"New pulmonary smear positive cases: females aged 15-24 years (not used after 2012)"
"new_sp_f2534","Notification",,"New pulmonary smear positive cases: females aged 25-34 years (not used after 2012)"
"new_sp_f3544","Notification",,"New pulmonary smear positive cases: females aged 35-44 years (not used after 2012)"
"new_sp_f4554","Notification",,"New pulmonary smear positive cases: females aged 45-54 years (not used after 2012)"
"new_sp_f514","Notification",,"New pulmonary smear positive cases: females aged 5-14 years (not used after 2012)"
"new_sp_f5564","Notification",,"New pulmonary smear positive cases: females aged 55-64 years (not used after 2012)"
"new_sp_f65","Notification",,"New pulmonary smear positive cases: females aged 65 and over (not used after 2012)"
"new_sp_fu","Notification",,"New pulmonary smear positive cases: females age unknown (not used after 2012)"
"new_sp_m014","Notification",,"New pulmonary smear positive cases: males aged 0-14 years (not used after 2012)"
"new_sp_m04","Notification",,"New pulmonary smear positive cases: males aged 0-4 years (not used after 2012)"
"new_sp_m1524","Notification",,"New pulmonary smear positive cases: males aged 15-24 years (not used after 2012)"
"new_sp_m2534","Notification",,"New pulmonary smear positive cases: males aged 25-34 years (not used after 2012)"
"new_sp_m3544","Notification",,"New pulmonary smear positive cases: males aged 35-44 years (not used after 2012)"
"new_sp_m4554","Notification",,"New pulmonary smear positive cases: males aged 45-54 years (not used after 2012)"
"new_sp_m514","Notification",,"New pulmonary smear positive cases: males aged 5-14 years (not used after 2012)"
"new_sp_m5564","Notification",,"New pulmonary smear positive cases: males aged 55-64 years (not used after 2012)"
"new_sp_m65","Notification",,"New pulmonary smear positive cases: males aged 65 years and over (not used after 2012)"
"new_sp_mu","Notification",,"New pulmonary smear positive cases: males age unknown (not used after 2012)"
"new_su","Notification",,"New pulmonary smear unknown/not done cases"
"newinc_rdx","Notification",,"(if rdx_data_available=60) Number of new and relapse cases notified and tested using a WHO-recommended rapid diagnostic (for example Xpert MTB/RIF) at the time of TB diagnosis (regardless of test result)"
"newrel_art","Notification",,"HIV-positive new and relapse (or all, if newrel_tbhiv_flg = 0 and year > 2015) TB patients started or continued on antiretroviral therapy"
"newrel_f014","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 0-14 years"
"newrel_f04","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 0-4 years"
"newrel_f1524","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 15-24 years"
"newrel_f15plus","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 15 years and over"
"newrel_f2534","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 25-34 years"
"newrel_f3544","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 35-44 years"
"newrel_f4554","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 45-54 years"
"newrel_f514","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 5-14 years"
"newrel_f5564","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 55-64 years"
"newrel_f65","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 65 years and over"
"newrel_fu","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females age unknown"
"newrel_hivpos","Notification",,"Number of new and relapse  (or all, if newrel_tbhiv_flg = 0 and year > 2015) TB patients recorded as HIV-positive"
"newrel_hivtest","Notification",,"Number of new and relapse (or all, if newrel_tbhiv_flg = 0 and year > 2015) TB patients tested for HIV at the time of TB diagnosis or with known HIV status at the time of TB diagnosis"
"newrel_m014","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 0-14 years"
"newrel_m04","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 0-4 years"
"newrel_m1524","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 15-24 years"
"newrel_m15plus","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 15 years and over"
"newrel_m2534","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 25-34 years"
"newrel_m3544","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 35-44 years"
"newrel_m4554","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 45-54 years"
"newrel_m514","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 5-14 years"
"newrel_m5564","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 55-64 years"
"newrel_m65","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 65 years and over"
"newrel_mu","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males age unknown"
"newrel_sexunk014","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 0-14 years"
"newrel_sexunk04","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 0-4 years"
"newrel_sexunk15plus","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 15 years and over"
"newrel_sexunk514","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 5-14 years"
"newrel_sexunkageunk","Notification",,"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, age unknown"
"newrel_tbhiv_flg","Notification","0=No; 1=Yes.","Are data on HIV testing, HIV positivity and provision of antiretroviral therapy (ART) restricted to new and relapse TB cases only?"
"newret_oth","Notification",,"Other cases not included in new and re-treatment case numbers"
"notif_foreign","Notification",,"New and re-treatment TB cases among foreign-born individuals"
"rdst_new","Notification",,"Number of TB cases (pulmonary or extrapulmonary) tested for susceptibility to rifampicin using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF), before or after starting treatment: new cases"
"rdst_ret","Notification",,"Number of TB cases (pulmonary or extrapulmonary) tested for susceptibility to rifampicin using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF), before or after starting treatment: previously treated cases"
"rdst_unk","Notification",,"Number of TB cases (pulmonary or extrapulmonary) tested for susceptibility to rifampicin using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF), before or after starting treatment: cases with unknown previous TB treatment history"
"rdx_data_available","Notification","0=No; 60= Yes available from the routine surveillance system; 61=Yes  estimated from a survey of a random sample of medical records or treatment cards of TB patients representative of the national TB patient population","Are data available on the number of new and relapse cases tested using a WHO-recommended rapid diagnostic during the reporting year?"
"rdxsurvey_newinc","Notification",,"(if rdx_data_available=61) Number of new and relapse cases whose medical records or treatment cards were included in the survey"
"rdxsurvey_newinc_rdx","Notification",,"(if rdx_data_available=61) Among the cases reported in rdxsurvey_newinc the number tested using a WHO-recommended rapid diagnostic (such as Xpert MTB/RIF) at the time of TB diagnosis (regardless of test result)"
"rel_in_agesex_flg","Notification","0=No; 1=Yes.","Are all relapse cases included with new cases in the disaggregations by age and sex?"
"ret_nrel","Notification",,"Previously treated patients, excluding relapse cases (pulmonary or extrapulmonary, bacteriologically confirmed or clinically diagnosed)"
"ret_oth","Notification",,"Other re-treatment cases"
"ret_rel","Notification",,"Relapse cases"
"ret_rel_clindx","Notification",,"Relapse pulmonary clinically diagnosed TB cases (not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment)."
"ret_rel_ep","Notification",,"Relapse extrapulmonary cases (bacteriologically confirmed or clinically diagnosed)"
"ret_rel_labconf","Notification",,"Relapse  pulmonary bacteriologically confirmed TB cases (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF)."
"ret_tad","Notification",,"Treatment after default cases"
"ret_taf","Notification",,"Treatment after failure cases"
"rr_sldst","Notification",,"Number of laboratory-confirmed RR-TB or MDR-TB cases tested for susceptibility to second-line drugs (fluoroquinolones and second-line injectable agents)"
"unconf_mdr_tx","Notification",,"Number of MDR-TB (not laboratory-confirmed) patients who started treatment for MDR-TB"
"unconf_rrmdr_tx","Notification",,"Number of patients (not laboratory-confirmed as having rifampicin-resistant (RR-TB) or multidrg-resistant TB (MDR-TB)) who started treatment for MDR-TB"
"xdr","Notification",,"Drug resistance surveillance: Among MDR-TB patients with drug susceptibility test results for any fluoroquinolone (FQ) and any second-line injectable agent (2LI) (variable mdr_dst_rlt): number with any resistance to both FQ and 2LI (i.e. XDR-TB)"
"xpert_dr_r_new","Notification",,"Among new pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay: number with resistance to rifampicin"
"xpert_dr_r_ret","Notification",,"Among previously treated pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay: number with resistance to rifampicin"
"xpert_dr_r_unk","Notification",,"Among pulmonary TB patients with unknown previous TB treatment history with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay: number with resistance to rifampicin"
"xpert_new","Notification",,"Number of new pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay"
"xpert_ret","Notification",,"Number of previously treated pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay"
"xpert_unk","Notification",,"Number of pulmonary TB patients with unknown previous TB treatment history with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay"
"c_new_snep_tsr","Outcomes",,"Treatment success rate for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases, percent  (not used after 2011)"
"c_new_sp_tsr","Outcomes",,"Treatment success rate for new pulmonary smear-positive (and/or culture-positive) cases, percent  (not used after 2011)"
"c_new_tsr","Outcomes",,"Treatment success rate for all new cases (including relapse cases if rel_with_new_flg = 1), percent"
"c_ret_tsr","Outcomes",,"Treatment success rate for re-treatment cases (excluding relapse cases if rel_with_new_flg = 1), percent"
"c_tbhiv_tsr","Outcomes",,"Treatment success rate for HIV-positive TB cases, percent"
"hiv_new_snep_cmplt","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: completed  (not used after 2011)"
"hiv_new_snep_coh","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: cohort size  (not used after 2011)"
"hiv_new_snep_def","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: defaulted  (not used after 2011)"
"hiv_new_snep_died","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: died  (not used after 2011)"
"hiv_new_snep_fail","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: failed (not used after 2011)"
"hiv_new_sp_cmplt","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: completed (not used after 2011)"
"hiv_new_sp_coh","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: cohort size (not used after 2011)"
"hiv_new_sp_cur","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: cured (not used after 2011)"
"hiv_new_sp_def","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: defaulted (not used after 2011)"
"hiv_new_sp_died","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: died (not used after 2011)"
"hiv_new_sp_fail","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: failed (not used after 2011)"
"hiv_ret_cmplt","Outcomes",,"Outcomes for re-treatment HIV-positive TB cases: completed (not used after 2011)"
"hiv_ret_coh","Outcomes",,"Outcomes for re-treatment HIV-positive TB cases: cohort size (not used after 2011)"
"hiv_ret_cur","Outcomes",,"Outcomes for re-treatment HIV-positive TB cases: cured (not used after 2011)"
"hiv_ret_def","Outcomes",,"Outcomes for re-treatment HIV-positive TB cases: defaulted (not used after 2011)"
"hiv_ret_died","Outcomes",,"Outcomes for re-treatment HIV-positive TB cases: died (not used after 2011)"
"hiv_ret_fail","Outcomes",,"Outcomes for re-treatment HIV-positive TB cases: failed (not used after 2011)"
"mdr_coh","Outcomes",,"Outcomes for MDR-TB cases: cohort size"
"mdr_died","Outcomes",,"Outcomes for MDR-TB cases: died"
"mdr_fail","Outcomes",,"Outcomes for MDR-TB cases: treatment failed"
"mdr_lost","Outcomes",,"Outcomes for MDR-TB cases: lost to follow-up"
"mdr_succ","Outcomes",,"Outcomes for MDR-TB cases: treatment success (Cured or treatment completed)"
"new_snep_cmplt","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: completed (not used after 2011)"
"new_snep_coh","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: cohort size (not used after 2011)"
"new_snep_def","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: defauled (not used after 2011)"
"new_snep_died","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: died (not used after 2011)"
"new_snep_fail","Outcomes",,"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: failed (not used after 2011)"
"new_sp_cmplt","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: completed (not used after 2011)"
"new_sp_coh","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: cohort size (not used after 2011)"
"new_sp_cur","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: cured (not used after 2011)"
"new_sp_def","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: defaulted (not used after 2011)"
"new_sp_died","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: died (not used after 2011)"
"new_sp_fail","Outcomes",,"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: failed (not used after 2011)"
"newrel_coh","Outcomes",,"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): cohort size"
"newrel_died","Outcomes",,"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): died"
"newrel_fail","Outcomes",,"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): treatment failed"
"newrel_lost","Outcomes",,"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): lost to follow-up"
"newrel_succ","Outcomes",,"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): treatment success (cured or treatment completed)"
"rel_with_new_flg","Outcomes","0=No; 1=Yes;","Are outcomes of relapse cases included in the newrel outcome variables?"
"rep_meth","Outcomes","100=smear;101=culture;102=smear or culture;","Method of confirmation used to report treatment outcomes of pulmonary cases  (not used after 2011)"
"ret_cmplt","Outcomes",,"Outcomes for re-treatment cases: completed  (not used after 2011)"
"ret_coh","Outcomes",,"Outcomes for re-treatment cases: cohort size (not used after 2011)"
"ret_cur","Outcomes",,"Outcomes for re-treatment cases: cured (not used after 2011)"
"ret_def","Outcomes",,"Outcomes for re-treatment cases: defaulted (not used after 2011)"
"ret_died","Outcomes",,"Outcomes for re-treatment cases: died (not used after 2011)"
"ret_fail","Outcomes",,"Outcomes for re-treatment cases: failed (not used after 2011)"
"ret_nrel_coh","Outcomes",,"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): cohort size"
"ret_nrel_died","Outcomes",,"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): died"
"ret_nrel_fail","Outcomes",,"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): treatment failed"
"ret_nrel_lost","Outcomes",,"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): lost to follow-up"
"ret_nrel_succ","Outcomes",,"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): treatment success (cured or treatment completed)"
"tbhiv_coh","Outcomes",,"Outcomes for HIV-positive TB cases, all types: cohort size"
"tbhiv_died","Outcomes",,"Outcomes for HIV-positive TB cases, all types: died"
"tbhiv_fail","Outcomes",,"Outcomes for HIV-positive TB cases, all types: treatment failed"
"tbhiv_lost","Outcomes",,"Outcomes for HIV-positive TB cases, all types: lost to follow-up"
"tbhiv_succ","Outcomes",,"Outcomes for HIV-positive TB cases, all types: treatment success (cured or treatment completed)"
"xdr_coh","Outcomes",,"Outcomes for XDR-TB cases: cohort size"
"xdr_died","Outcomes",,"Outcomes for XDR-TB cases: number died"
"xdr_fail","Outcomes",,"Outcomes for XDR-TB cases: number whose treatment failed"
"xdr_lost","Outcomes",,"Outcomes for XDR-TB cases: lost to follow-up"
"xdr_succ","Outcomes",,"Outcomes for XDR-TB cases: treatment success (Cured or treatment completed)"
"caseb_err_nat","Strategy","0=No; 42=Yes (all TB patients in the country); 43=Yes (but only for MDR-TB patients countrywide)","Did the National Treatment Programme keep (or have access to) an electronic case-based database for TB patients on treatment at national level"
"digital_adherence_support","Strategy","3=don't know; 210=Not used by any treatment centre; 211=Used only by public sector treatment centres; 212=Used only by private sector treatment centres; 213=Used by public and private  sector treatment centres","Did any treatment centre use digital technologies such as short text messaging via mobile phones, video-communication or electronic medication monitors to support TB medication adherence in patients at risk of interrupting treatment?"
"eol_care","Strategy","0=No; 1=yes","Is there a component in the TB programme that provides palliative and end-of-life care to patients who have failed MDR-TB treatment or who have life-threatening sequelae of disease?"
"free_dx_followup","Strategy","0=No; 1=yes","Does national policy indicate that TB diagnostic and follow-up tests provided through the national TB programme are free of charge or that fees can be fully reimbursed through health insurance, or both, for all people with signs or symptoms of TB?"
"hcw_tb_infected","Strategy",,"Number of health-care workers who had TB"
"hcw_tot","Strategy",,"Total number of health-care workers who were working in the country in the public and private sector"
"mdr_tx_nonntp","Strategy",,"Number of patients started on MDR-TB treatment by non-NTP providers in the reporting year"
"priv_new_dx","Strategy",,"Number of new cases of TB diagnosed according to National Treatment Programme (NTP)  guidelines by private providers"
"pub_new_dx","Strategy",,"Number of new cases of TB diagnosed according to National Treatment Programme (NTP)  guidelines by non-NTP public providers"
"universal_dst","Strategy","0=No; 1=yes","Does national policy and the diagnostic algorithm indicate there is universal access to drug susceptibility testing?"
"wrd_initial_test","Strategy","0=No; 1=yes","Does national policy and the diagnostic algorithm indicate a WHO-recommended rapid diagnostic as the initial diagnostic test for all people with signs or symptoms of TB?"
